Table 5.
Factor | Overall survival | Disease-free survival | ||||
---|---|---|---|---|---|---|
|
|
|||||
RRa | 95% CIb | P | RRa | 95% CIb | P | |
Gender | ||||||
Male/Female | 1.083 | 0.672-2.817 | 0.853 | 1.214 | 0.713-2.901 | 0.879 |
Age, years | ||||||
> 55/≤ 55 | 1.348 | 0.621-2.674 | 0.506 | 1.268 | 0.603-2.593 | 0.623 |
Tumor size, cm | ||||||
≤ 4/> 4 | 7.325 | 4.267-12.383 | 0.031 | 7.865 | 4.612-13.013 | 0.019 |
Tumor pathology stage | ||||||
T3-T4/T1-2 | 8.455 | 5.216-13.478 | 0.017 | 8.633 | 5.341-13.652 | 0.014 |
Grading | ||||||
3, 4/1, 2 | 3.231 | 2.216-6.485 | 0.022 | 2.975 | 2.014-3.880 | 0.015 |
Lymph node metastasis | ||||||
yes/no | 3.452 | 2.421-6.533 | 0.012 | 3.623 | 2.583-6.632 | 0.008 |
Vascular invasion | ||||||
yes/no | 2.286 | 1.783-5.043 | 0.017 | 2.632 | 1.937-5.232 | 0.011 |
Tobacco smoking | ||||||
yes/no | 1.476 | 0.843-3.246 | 0.683 | 1.547 | 0.891-3.359 | 0.579 |
DNMT1 status | ||||||
positive/negative | 1.598 | 0.926-2.021 | 0.036 | 1.683 | 1.053-2.416 | 0.121 |
DNMT3A status | ||||||
positive/negative | 1.662 | 0.985-2.376 | 0.208 | 1.717 | 1.097-2.502 | 0.031 |
DNMT3B status | ||||||
positive/negative | 1.713 | 1.035-2.681 | 0.192 | 1.845 | 1.106-2.583 | 0.023 |
RR, relative risk;
95% CI, 95% confidence interval.